4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Muyi Yang, Zhenyu Diao, Zhiyin Wang, Guijun Yan, Guangfeng Zhao, Mingming Zheng, Anyi Dai, Yimin Dai, Yali Hu. Pravastatin alleviates lipopolysaccharide-induced placental TLR4 over-activation and promotes uterine arteriole remodeling without impairing rat fetal development[J]. The Journal of Biomedical Research, 2018, 32(4): 288-297. DOI: 10.7555/JBR.32.20180039
Citation: Muyi Yang, Zhenyu Diao, Zhiyin Wang, Guijun Yan, Guangfeng Zhao, Mingming Zheng, Anyi Dai, Yimin Dai, Yali Hu. Pravastatin alleviates lipopolysaccharide-induced placental TLR4 over-activation and promotes uterine arteriole remodeling without impairing rat fetal development[J]. The Journal of Biomedical Research, 2018, 32(4): 288-297. DOI: 10.7555/JBR.32.20180039

Pravastatin alleviates lipopolysaccharide-induced placental TLR4 over-activation and promotes uterine arteriole remodeling without impairing rat fetal development

Funds: 

This work was funded by the following Grants:National Natural Science Foundation of China, Grant/Award Number: 81370724, 81571463 and 81401225

Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province for the year 2016, Grant/Award Number: KYLX16_1111.We thank Professor Juan Li for assistance with the experiments, Professor Biyun Xu for suggestions on statistical analysis and Professor Yan Zhou for valuable discussion.

More Information
  • Received Date: April 16, 2018
  • Revised Date: March 22, 2018
  • Preeclampsia is associated with over-activation of the innate immune system in the placenta, in which toll-like receptor 4 (TLR4) plays an essential part. With their potent anti-inflammatory effects, statins have been suggested as potential prevention or treatment of preeclampsia, although evidence remains inadequate. Herewith, we investigated whether pravastatin could ameliorate preeclampsia-like phenotypes in a previously established lipopolysaccharide (LPS)-induced rat preeclampsia model, through targeting the TLR4/NF-kB pathway. The results showed that pravastatin reduced the blood pressure [maximum decline on gestational day (GD) 12, (101.33 ± 2.49) mmHg vs. (118.3 ± 1.37) mmHg, P < 0.05] and urine protein level [maximum decline on GD9, (3,726.23 ± 1,572.86) mg vs. (1,991.03 ± 609.37) mg, P < 0.05], which were elevated following LPS administration. Pravastatin also significantly reduced the rate of fetal growth restriction in LPS-treated rats (34.10% vs. 8.99%, P < 0.05). Further pathological analyses suggested a restoration of normal spiral artery remodeling in preeclampsia rats by pravastatin treatment. These effects of pravastatin were associated with decreased TLR4/NF-kB protein levels in the placenta and IL-6/MCP-1 levels in serum. Additionally, no obvious abnormalities in fetal liver, brain, and kidney were found after administration of pravastatin. These results provide supportive evidence for use of pravastatin in preventing preeclampsia.
  • Related Articles

    [1]Yan Gu, Ke Wei, Jun Wang. Phase separation and transcriptional regulation in cancer development[J]. The Journal of Biomedical Research, 2024, 38(4): 307-321. DOI: 10.7555/JBR.37.20230214
    [2]Yuanyuan Wang, Liya Liu, Mingyan Lin. Psychiatric risk gene transcription factor 4 preferentially regulates cortical interneuron neurogenesis during early brain development[J]. The Journal of Biomedical Research, 2022, 36(4): 242-254. DOI: 10.7555/JBR.36.20220074
    [3]Qing Cao, Yan Shen, Wei Zheng, Hao Liu, Chen Liu. Tcf7l1 promotes transcription of Kruppel-like factor 4 during Xenopus embryogenesis[J]. The Journal of Biomedical Research, 2018, 32(3): 215-221. DOI: 10.7555/JBR.32.20170056
    [4]Xinglong Yang, Jingdong Zhang, Lian Duan, Huangui Xiong, Yanping Jiang, Houcheng Liang. Microglia activation mediated by toll-like receptor-4 impairs brain white matter tracts in rats[J]. The Journal of Biomedical Research, 2018, 32(2): 136-144. DOI: 10.7555/JBR.32.20170033
    [5]Eun Suk An, Dongsun Park, Young-Hwan Ban, Jieun Choi, Da Woom Seo, Yoon Bok Lee, Mi Yae Shon, Ehn-Kyoung Choi, Yun-Bae Kim. Effects of a soybean milk product on feto-neonatal development in rats[J]. The Journal of Biomedical Research, 2018, 32(1): 51-57. DOI: 10.7555/JBR.31.20170067
    [6]Wolfgang J. Schneider. Lipid transport to avian oocytes and to the developing embryo[J]. The Journal of Biomedical Research, 2016, 30(3): 174-180. DOI: 10.7555/JBR.30.20150048
    [7]Jiliang Zhou. An emerging role for Hippo-YAP signaling in cardiovascular development[J]. The Journal of Biomedical Research, 2014, 28(4): 251-254. DOI: 10.7555/JBR.28.20140020
    [8]Li Yuan, Xinxin Li, Jiaojiao Feng, Chenyang Yin, Fang Yuan, Xinru Wang. IRE1α is essential for Xenopus pancreas development[J]. The Journal of Biomedical Research, 2014, 28(2): 123-131. DOI: 10.7555/JBR.28.20130076
    [9]Fabrizio Dal Moro. The role of lysyl oxidase-like 1 and fibulin-5 in the development of atherosclerosis and pelvic organ prolapse[J]. The Journal of Biomedical Research, 2013, 27(3): 242-242. DOI: 10.7555/JBR.27.20130045
    [10]Hua Huang, Juan Wu, Guangfu Jin, Hanze Zhang, Yanbing Ding, Zhaolai Hua, Yan Zhou, Yan Xue, Yan Lu, Zhibin Hu, Yaochu Xu, Hongbing Shen. A 5'-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population[J]. The Journal of Biomedical Research, 2010, 24(2): 100-106.
  • Cited by

    Periodical cited type(4)

    1. De la Cruz-Color L, Dominguez-Rosales JA, Maldonado-González M, et al. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans. Int J Mol Sci, 2024, 25(12): 6420. DOI:10.3390/ijms25126420
    2. Casado ME, Collado-Pérez R, Frago LM, et al. Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies. Int J Mol Sci, 2023, 24(2): 1422. DOI:10.3390/ijms24021422
    3. Chenouard V, Remy S, Tesson L, et al. Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models. Front Genet, 2021, 12: 615491. DOI:10.3389/fgene.2021.615491
    4. Lin SY, Yang CP, Wang YY, et al. Interleukin-4 Improves Metabolic Abnormalities in Leptin-Deficient and High-Fat Diet Mice. Int J Mol Sci, 2020, 21(12): 4451. DOI:10.3390/ijms21124451

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3645) PDF downloads (162) Cited by(4)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return